Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05986799
Other study ID # 23-RD-05-AY-001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 13, 2023
Est. completion date November 30, 2023

Study information

Verified date August 2023
Source Amway (China) R&D Center
Contact Charlie Zhang, MD
Phone +8613901981272
Email charlie.zhang@sprimmedical.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This goal of this two arms, randomized, double-blind controlled trial is to study whether Amway herbal drink could improve skin anti-aging in the middle-aged people of 30-60 years old. The main questions it aims to answer are: 1. whether skin elasticity will be improved measured by Cutometer 2. whether skin wrinkles/roughness/pores will be improved measured by Antera 3D 30 eligible Participants will be enrolled in one center and randomly assigned to two study groups (Amway herbal drink group and placebo drink group). Up to four study visits will be made by the subject over a 3-month period intervention and all clinical data will be captured and recorded into CTMS (Clinical Trial Management System) for data analysis and reporting. Researchers will compare Amway herbal drink group and placebo drink group to see if consumption of Amway herbal drink could significantly improve skin anti-aging at the end of the study.


Recruitment information / eligibility

Status Recruiting
Enrollment 30
Est. completion date November 30, 2023
Est. primary completion date November 15, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 30 Years to 60 Years
Eligibility Inclusion Criteria: - Male and female subjects, aged 30 to 60 years, with a gender ratio of 3:7; - Subjects are healthy; - Visual assessment, smoothness is greater than or equal to 3 points (according to the Test Method of Efficacy Measurement of Nourishing Cosmetic Products issued by Chinese Association of Fragrance Flavor and Cosmetic Industries, the smaller the index, the better. Please refer to appendix II); - Visual assessment, the gloss index is greater than or equal to 4 points (according to the Unilever Radiance Scale, the smaller the index is the better. Please refer to appendix III); - Subjects could not use facial whitening and moisturizing products during the trial; - Agree not to take other oral products with similar efficacy (such as collagen, sodium hyaluronate, etc.) during the trial. During the trial, participants agreed not to take any drugs or supplements. Do not do any medical beauty projects during the trial, do not participate in other interventional clinical research; - Have a full understanding of the purpose, benefits, and possible risks and side effects of the study; - Willing to comply with all research requirements and procedures; - Understand the test procedure, read, and sign an appropriate Informed Consent Form indicating their willingness to participate. Exclusion Criteria: - Use of any medications or supplements that may alter skin properties during the first 3 months of enrollment; - Skin disease patients; - Ggastrointestinal symptoms being treated; - Lactose intolerance, allergy to fish and its products; - Present with other organic diseases that affect intestinal function, such as history of gastrointestinal resection, colon or rectal cancer, inflammatory bowel disease, diabetes, hyperthyroidism or hypothyroidism, congenital megacolon, scleroderma, anorexia nervosa, etc.; - Controlling diet, exercising more, or taking medications to control weight or affect appetite in the last 3 months; - Subjects have any of the following medical history or clinical findings that may affect the evaluation of the trial effect: significant gastrointestinal disorders, liver, kidney, endocrine, hematological, respiratory and cardiovascular diseases; - Abuse of alcohol or other illicit drugs, supplements currently or in the past, or OTC prescription drugs that may cause intestinal dysfunction or interfere with the evaluation of trial effects; - Frequent use of drugs that may affect gastrointestinal function or the immune system, as judged by the researcher; - Use of laxatives or other digestive substances in the 2 weeks prior to trial commencement; - Women who are pregnant or breastfeeding, or who plan to become pregnant during the trial; - PI considers that volunteers cannot fully cooperate with the trial arrangement.

Study Design


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Amway Herbal Drink
1 sachet per time, 3 times daily, for 3 months period.
Placebo Drink
1 sachet per time, 3 times daily, for 3 months period.

Locations

Country Name City State
China Ai You Mei Medical Beauty Clinic Jinhua Zhejiang

Sponsors (1)

Lead Sponsor Collaborator
Amway (China) R&D Center

Country where clinical trial is conducted

China, 

References & Publications (11)

Benatrehina PA, Pan L, Naman CB, Li J, Kinghorn AD. Usage, biological activity, and safety of selected botanical dietary supplements consumed in the United States. J Tradit Complement Med. 2018 Mar 2;8(2):267-277. doi: 10.1016/j.jtcme.2018.01.006. eCollection 2018 Apr. — View Citation

Binic I, Lazarevic V, Ljubenovic M, Mojsa J, Sokolovic D. Skin ageing: natural weapons and strategies. Evid Based Complement Alternat Med. 2013;2013:827248. doi: 10.1155/2013/827248. Epub 2013 Jan 29. — View Citation

Blanpain C, Fuchs E. Epidermal stem cells of the skin. Annu Rev Cell Dev Biol. 2006;22:339-73. doi: 10.1146/annurev.cellbio.22.010305.104357. — View Citation

Blume-Peytavi U, Kottner J, Sterry W, Hodin MW, Griffiths TW, Watson RE, Hay RJ, Griffiths CE. Age-Associated Skin Conditions and Diseases: Current Perspectives and Future Options. Gerontologist. 2016 Apr;56 Suppl 2:S230-42. doi: 10.1093/geront/gnw003. — View Citation

Cao C, Xiao Z, Wu Y, Ge C. Diet and Skin Aging-From the Perspective of Food Nutrition. Nutrients. 2020 Mar 24;12(3):870. doi: 10.3390/nu12030870. — View Citation

Chaikul P, Kanlayavattanakul M, Somkumnerd J, Lourith N. Phyllanthus emblica L. (amla) branch: A safe and effective ingredient against skin aging. J Tradit Complement Med. 2021 Feb 9;11(5):390-399. doi: 10.1016/j.jtcme.2021.02.004. eCollection 2021 Sep. — View Citation

Fam VW, Charoenwoodhipong P, Sivamani RK, Holt RR, Keen CL, Hackman RM. Plant-Based Foods for Skin Health: A Narrative Review. J Acad Nutr Diet. 2022 Mar;122(3):614-629. doi: 10.1016/j.jand.2021.10.024. Epub 2021 Oct 30. — View Citation

Lee HR, Ryu HG, Lee Y, Park JA, Kim S, Lee CE, Jung S, Lee KH. Effect of Aronia Extract on Collagen Synthesis in Human Skin Cell and Dermal Equivalent. Oxid Med Cell Longev. 2022 Aug 8;2022:4392256. doi: 10.1155/2022/4392256. eCollection 2022. — View Citation

Michalak M. Plant-Derived Antioxidants: Significance in Skin Health and the Ageing Process. Int J Mol Sci. 2022 Jan 6;23(2):585. doi: 10.3390/ijms23020585. — View Citation

Zhang S, Duan E. Fighting against Skin Aging: The Way from Bench to Bedside. Cell Transplant. 2018 May;27(5):729-738. doi: 10.1177/0963689717725755. Epub 2018 Apr 25. — View Citation

Zhou H, Zhou L, Li B, Yue R. Anti-cyclooxygenase, anti-glycation, and anti-skin aging effect of Dendrobium officinale flowers' aqueous extract and its phytochemical validation in aging. Front Immunol. 2023 Mar 17;14:1095848. doi: 10.3389/fimmu.2023.1095848. eCollection 2023. — View Citation

* Note: There are 11 references in allClick here to view all references

Outcome

Type Measure Description Time frame Safety issue
Primary Change of Skin Elasticity The changes of skin elasticity from baseline to day 90 by CK Cutometer MPA580 baseline day 0, day 90
Secondary Change of Facial Lines/Wrinkles The changes of facial lines/wrinkles by Miravex Antera 3D imaging system baseline day 0, day 45, day 90
See also
  Status Clinical Trial Phase
Active, not recruiting NCT06140628 - A 28-day Clinical Study on Facial Skin Rejuvenation N/A
Completed NCT01971736 - Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening N/A
Completed NCT01713985 - Feasibility Study: Evaluation of Ulthera Versus Thermage for Treating the Face and Neck N/A
Completed NCT01708252 - Feasibility Study: Treatment of Post-surgery and Surgery Naive Patients Who Failed to Respond to a Previous Ulthera Treatment N/A
Completed NCT01708382 - Feasibility Study: Lifting and Tightening of the Elbows N/A
Completed NCT01713998 - Treatment of the Face and Neck With Lower Ulthera System Energy Settings N/A
Completed NCT04296201 - Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology N/A
Completed NCT06000839 - A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology) N/A
Completed NCT06366503 - Evaluating Procedure Pairing of a Post-Procedure Cream Versus a Comparator in Patients Treated With Fractional Ablative CO2 Laser for Facial Rejuvenation N/A
Completed NCT05929625 - Radiofrequency and Ultrasound for Improvement of Skin Laxity and Wrinkles: Efficacy and Safety Evaluation N/A
Terminated NCT01713569 - Feasibility Study: Histological Characterization After Treatment With the Ulthera® System N/A
Completed NCT01519934 - A Retrospective Study to Evaluate the Effectiveness of the Ulthera System N/A
Completed NCT05605691 - Post-Market Lower Eyelid Treatment With Renuvion in Greece N/A
Completed NCT04477187 - Clinical Assessment of Skin Tightening and Contour Change of Submental Tissue Using Bipolar Radiofrequency Microneedling N/A
Completed NCT05590364 - Aesthetic Performance and Tolerance of an Injective Intradermal Treatment for the Skin Roughness and Laxity of Back of the Hands N/A
Recruiting NCT06243744 - Histological Evaluation of Human Skin Bx to Assess the Effects of APR Tx as an Adjunct Procedure in Facelift Surgery N/A
Completed NCT04146584 - Safety and Efficacy of SofWave Treatment to Lift Lax Tissue in the Submental and Neck Zones and to Lift the Eyebrow Phase 2
Recruiting NCT05750901 - Evaluation of Fractional Ablative Laser Treatment for Skin Conditions N/A
Completed NCT04721600 - Evaluation of the Evoke Radiofrequency Device for Improvement of Skin Appearance N/A
Recruiting NCT06157567 - Clinical Feasibility Study to Evaluate the Safety and Performance of the Profound Matrix System N/A